Ágreda Fernández, Mario http://orcid.org/0000-0001-7663-9554
Origüen, Julia http://orcid.org/0000-0002-6507-0363
Rodriguez-Goncer, Isabel http://orcid.org/0000-0003-2150-5748
San Juan, Rafael http://orcid.org/0000-0003-3446-1991
López-Medrano, Francisco http://orcid.org/0000-0001-5333-7529
Parra, Patricia http://orcid.org/0000-0002-5852-5884
Ruiz-Merlo, Tamara http://orcid.org/0000-0002-8261-6057
Redondo, Natalia http://orcid.org/0000-0001-9356-8102
Orellana, María Ángeles http://orcid.org/0000-0002-2696-8613
Aguado, José María http://orcid.org/0000-0002-9520-8255
Fernández-Ruiz, Mario http://orcid.org/0000-0002-0315-8001
Funding for this research was provided by:
Instituto de Salud Carlos III (CP18/00073)
Merck Sharp and Dohme
Article History
Received: 27 April 2023
Accepted: 28 November 2023
First Online: 11 December 2023
DeclarationsDeclaration
:
: The study protocol was submitted for evaluation and approved by the Ethics and Clinical Research Committee (CEIC) of the Research Institute Hospital “12 de Octubre” (i + 12). Informed consent was signed by all participants before inclusion in the study. All information related to the study was treated as strictly confidential in accordance with Organic Law 3/2018, of December 5, on Personal Data Protection and Guarantee of Digital Rights and the Biomedical Research Law 14/2007. The study was performed in accordance with the ethical principles set out in the latest version of the Helsinki
: Not applicable.
: The authors declare no competing interests.